rs11708606

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032638.5(GATA2):​c.1018-19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.18 in 1,611,562 control chromosomes in the GnomAD database, including 27,415 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2468 hom., cov: 33)
Exomes 𝑓: 0.18 ( 24947 hom. )

Consequence

GATA2
NM_032638.5 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.0490

Publications

11 publications found
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
GATA2 Gene-Disease associations (from GenCC):
  • deafness-lymphedema-leukemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • GATA2 deficiency with susceptibility to MDS/AML
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • monocytopenia with susceptibility to infections
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • myelodysplastic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032638.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 3-128481963-G-A is Benign according to our data. Variant chr3-128481963-G-A is described in ClinVar as Benign. ClinVar VariationId is 257561.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032638.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GATA2
NM_001145661.2
MANE Plus Clinical
c.1018-19C>T
intron
N/ANP_001139133.1P23769-1
GATA2
NM_032638.5
MANE Select
c.1018-19C>T
intron
N/ANP_116027.2
GATA2
NM_001145662.1
c.1018-61C>T
intron
N/ANP_001139134.1P23769-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GATA2
ENST00000341105.7
TSL:1 MANE Select
c.1018-19C>T
intron
N/AENSP00000345681.2P23769-1
GATA2
ENST00000487848.6
TSL:1 MANE Plus Clinical
c.1018-19C>T
intron
N/AENSP00000417074.1P23769-1
GATA2
ENST00000430265.6
TSL:1
c.1018-61C>T
intron
N/AENSP00000400259.2P23769-2

Frequencies

GnomAD3 genomes
AF:
0.174
AC:
26426
AN:
151922
Hom.:
2467
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.173
Gnomad AMI
AF:
0.205
Gnomad AMR
AF:
0.155
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.0534
Gnomad SAS
AF:
0.0722
Gnomad FIN
AF:
0.195
Gnomad MID
AF:
0.172
Gnomad NFE
AF:
0.194
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.156
AC:
38589
AN:
246728
AF XY:
0.156
show subpopulations
Gnomad AFR exome
AF:
0.174
Gnomad AMR exome
AF:
0.119
Gnomad ASJ exome
AF:
0.129
Gnomad EAS exome
AF:
0.0538
Gnomad FIN exome
AF:
0.191
Gnomad NFE exome
AF:
0.198
Gnomad OTH exome
AF:
0.175
GnomAD4 exome
AF:
0.181
AC:
263459
AN:
1459522
Hom.:
24947
Cov.:
34
AF XY:
0.177
AC XY:
128671
AN XY:
726092
show subpopulations
African (AFR)
AF:
0.176
AC:
5897
AN:
33472
American (AMR)
AF:
0.124
AC:
5536
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
3338
AN:
26128
East Asian (EAS)
AF:
0.0518
AC:
2055
AN:
39690
South Asian (SAS)
AF:
0.0851
AC:
7342
AN:
86250
European-Finnish (FIN)
AF:
0.191
AC:
9803
AN:
51398
Middle Eastern (MID)
AF:
0.170
AC:
979
AN:
5768
European-Non Finnish (NFE)
AF:
0.196
AC:
218008
AN:
1111776
Other (OTH)
AF:
0.174
AC:
10501
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
11113
22227
33340
44454
55567
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7526
15052
22578
30104
37630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.174
AC:
26441
AN:
152040
Hom.:
2468
Cov.:
33
AF XY:
0.171
AC XY:
12692
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.173
AC:
7157
AN:
41442
American (AMR)
AF:
0.155
AC:
2375
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
406
AN:
3468
East Asian (EAS)
AF:
0.0534
AC:
275
AN:
5152
South Asian (SAS)
AF:
0.0731
AC:
352
AN:
4816
European-Finnish (FIN)
AF:
0.195
AC:
2062
AN:
10588
Middle Eastern (MID)
AF:
0.178
AC:
52
AN:
292
European-Non Finnish (NFE)
AF:
0.194
AC:
13202
AN:
67964
Other (OTH)
AF:
0.176
AC:
373
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1090
2180
3270
4360
5450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
2027
Bravo
AF:
0.173
Asia WGS
AF:
0.0710
AC:
247
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
3
not provided (3)
-
-
1
Deafness-lymphedema-leukemia syndrome (1)
-
-
1
Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections (1)
-
-
1
Monocytopenia with susceptibility to infections (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
7.9
DANN
Benign
0.92
PhyloP100
-0.049
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11708606;
hg19: chr3-128200806;
COSMIC: COSV62004676;
COSMIC: COSV62004676;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.